Adjunctive topiramate in the maintenance treatment of bipolar disorders: An open-label study

Current Medical Research and Opinion

Volumn 20, Issue 6, 2004, Pages 843-847

  Lykouras, Lefteris ^a,b   Hatzimanolis, John ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bipolar disorder; Maintenance treatment; Novel antiepileptics; Topiramate

Indexed keywords

CARBAMAZEPINE; CLOMIPRAMINE; FLUOXETINE; LAMOTRIGINE; LITHIUM; OXCARBAZEPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE;

ADD ON THERAPY; ADULT; ANOREXIA; ARTICLE; BIPOLAR I DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; NAUSEA; SOMNOLENCE; VISUAL IMPAIRMENT;

ADULT; ANTICONVULSANTS; BIPOLAR DISORDER; FEMALE; FRUCTOSE; GREECE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 3042572715     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125003665     Document Type: Article

References (17)

1. Lenox RH, Manjii HK. Lithium. In: Nemeroff CB, Schatzberg AS, editors. Textbook of psychopharmacology, 2nd ed. Washington (DC): American Psychiatric Press; 1998. p. 379-429
2. Keck PE, McElroy SL. Antiepileptic drugs. In: Nemeroff CB, Schatzberg AS, editors. Textbook of psychopharmacology, 2nd ed. Washington (DC): American Psychiatric Press; 1994. p. 431-54
3. Keck PE, McElroy SL, Strakowski SM, Soutullo CA. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. J Clin Psychiatry 2000;61 (Suppl 4):33-8
4. Calabrese JR, Shelton MD, Rapport OJ, Kimmel SEQ. Bipolar disorder and the effectiveness of novel anticonvulsants. J Clin Psychiatry 2002;63(Suppl 3):5-9
5. Yathan LN. The role of novel antipsychotics in bipolar disorders. J Clin Psychiatry 2002;63(Suppl 3):1014
6. Kasper S, Stamenkovic M, Letmaier M, Schreinzer D. Atypical antipsychotics in mood disorders. Intern Clin Psychopharmacol 2000;17:1-10
7. Yatham LN, Kusumakar V, Calabrese JR, Rao R, Scarrow G, Kroeker G. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations. J Clin Psychiatry 2002;63:275-83
8. Shorvon SD. Safety of topiramate: adverse effects and relationship to dosing. Epilepsia 1996;37:518-22
9. Chengappa KNR, Gershon S, Levine J. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Bipolar Disorder 2001a;3:215-32
10. Maidment ID. The use of topiramate in mood stabilization. Annals Pharmacother 2002;36:1277-81
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington (DC): American Psychiatric Press. 1994
12. First MB, Spitzer RZ, Gibbon M, William JBW. Structural clinical interview for DSM-IV Axis I Disorders Clinical Version (SCID-IV). Washington (DC): American Psychiatric Press; 1997
13. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
15. Erfurth A, Kulin G. Topiramate monotherapy in the maintenance treatment of bipolar I disorder. Neuropsychobiology 2000;42(Suppl 1):50-1
16. Letmaler M, Schreinzer D, Wolf P, Kasper S. Topiramate as a mood stabilizer. Intern Clin Psychopharmacol 2001;16:295-8
17. Chengappa KNR, Levine J, Rathore D, Parepally H, Atzert R. Long term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case series. Eur Psychiatry 2001b;16:186-90